US manager eyes strong Nordic interest for its new biotech 2.0 fund

BNY Mellon Investment Management has launched a fund seeking to benefit from the growing gene therapy treatment market. The asset manager's director of Nordic distribution Viktoria von Kunow has high regional hopes for the new thematic fund.

BNY Mellon Investment Management's director Nordic Distribution Viktoria von Kunow | Photo: PR / BNY Mellon Investment Management

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Further reading

Related articles

Latest news

See all jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch